Invesco Ltd. Solid Biosciences Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $8,179 - $23,586	-19,021 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.74 - $1.79 $284 - $689	385 Added 2.07%	19,021 $23,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $7,763 - $11,301	-4,594 Reduced 19.78%	18,636 $32,000
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $7,566 - $11,984	3,179 Added 15.85%	23,230 $56,000
Q2 2021 Aug 17, 2021	BUY	$3.49 - $5.51 $69,977 - $110,481	20,051 New	20,051 $73,000
Q4 2019 Feb 14, 2020	SELL	$2.82 - $12.9 $227,520 - $1.04 Million	-80,681 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$4.33 - $11.64 $349,348 - $939,126	80,681 New	80,681 $834,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.